Skip to main content
Top
Published in:

01-10-2019 | Amyotrophic Lateral Sclerosis | Case report

Fampridine

Dizziness and nausea following off label use: case report

Published in: Reactions Weekly | Issue 1/2019

Login to get access

Excerpt

In a case series, 74-year-old woman was described, who developed dizziness and nausea during off-label treatment with fampridine for amyotrophic lateral sclerosis. The woman, who had amyotrophic lateral sclerosis, received off-label treatment with oral fampridine [4-aminopyridine] 20mg daily. Subsequently, she developed adverse reactions including dizziness and nausea [duration of treatment to reaction onsets and outcomes not stated]. After 4 months of treatment, fampridine was discontinued. …
Literature
Metadata
Title
Fampridine
Dizziness and nausea following off label use: case report
Publication date
01-10-2019
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2019
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-019-69908-x